trial · primary record
ACC-1898
Hepatocellular Carcinoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2028-12 |
| Primary endpoint | Incidence of Dose-Limiting Toxicities (DLTs) Part 1 (Dose Escalation) |
| Registry ID | NCT07252661 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:50.465Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07252661
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.